Lexie Lumen vs Otofonix Encore

The Lexie Lumen is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.5/5 in our lab testing, placing it in the top 60% of the OTC category. At $299, this behind-the-ear device uses disposable batteries and represents one of the more affordable entry points into amplification. In our standardized testing, the Lumen demonstrated notably strong feedback handling, scoring 5.0/5 in the tuned configuration—0.46 points above the category average. This excellent stability means users can expect minimal whistling during typical daily activities. Speech in noise performance scored 2.0/5, which is above the category average by 0.55 points, though still mixed in absolute terms. The device shows clear limitations in certain areas. Music streaming scored 0.0/5, falling 1.92 points below category average—prospective buyers who prioritize phone streaming for music or media should consider alternatives. Speech in quiet performance is also slightly below average at 2.5/5, a mixed result that may affect understanding in everyday conversation. The Lexie Lumen is best suited for budget-conscious first-time users who prioritize stable, feedback-free amplification over streaming capabilities. However, shoppers in this price range have several higher-performing alternatives available, including the Sony CRE-E10 and Lexie B2 Plus, both of which scored significantly higher in our testing.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.